Monday, April 19, 2021
Home Life Style Health & Fitness Single-Dose Of Covid19 Vaccine Triggers Antibody Response

Single-Dose Of Covid19 Vaccine Triggers Antibody Response

The primary target for Covid-19 vaccines is the spike protein, which is necessary for SARS-CoV-2's entry into cells

Researchers have developed a nanoparticle vaccine that elicits a virus-neutralizing antibody response after a single dose. The team, including Peter Kim from Stanford University in the US, said that the primary target for Covid-19 vaccines is the spike protein, which is necessary for SARS-CoV-2’s entry into cells.

Both of the vaccines are mRNA vaccines that cause human cells to temporarily produce the spike protein, triggering an immune response and antibody production. For the study, published in the ACS Central Science journal, the team wanted to try a different approach: a vaccine consisting of multiple copies of the spike protein displayed on ferritin nanoparticles, in a mice-based experiment.

Follow NewsGram on Twitter to stay updated about the World news.

Ferritin is an iron storage protein found in many organisms that self-assembles into a larger nanoparticle. Other proteins, such as viral antigens, can be fused to ferritin so that each nanoparticle displays several copies of the protein, which might cause a stronger immune response than a single copy.

vaccines
Both of the vaccines are mRNA vaccines. Pixabay

The researchers spliced spike protein and ferritin DNA together and then expressed the hybrid protein in cultured mammalian cells. The ferritin self-assembled into nanoparticles, each bearing eight copies of the spike protein trimer. The team purified the spike/ferritin particles and injected them into mice.

ALSO READ: Nanomaterial-Based Biosensing Platform That Detects Antibodies Of Virus

After a single immunization, mice produced neutralizing antibody titers that were at least two times higher than those in convalescent plasma from Covid-19 patients, and significantly higher than those in mice immunized with the spike protein alone. A second immunization 21 days later produced even higher antibody levels.

Although these results must be confirmed in human clinical trials, they suggest that the spike/ferritin nanoparticles may be a viable strategy for single-dose vaccination against Covid-19, the researchers said. (IANS)

STAY CONNECTED

19,517FansLike
362FollowersFollow
1,773FollowersFollow

Most Popular

In The Last 12 Months, 1 In Every 2 Indian Adults Was A Victim Of Cybercrime

More than one in two Indian adults (59 percent) experienced cybercrime in the last 12 months, as seven in 10 Indian adults (among those...

Here Are Some Ideas To Make Your Flooring Look More Appealing

Before finalizing the design of the flooring of your home, keep in mind some aspects such as textures, material, and finish. Decorating the floors...

Twelve Of Europe’s Top Football Clubs Formed A New Breakaway Super League

Twelve of Europe's top football clubs launched a breakaway Super League on Sunday, launching what is certain to be a bitter battle for control...

Here’s Why Both Underweight, Overweight Women Are At Higher Risk Of Miscarriages

Being underweight or overweight could significantly increase your risk of experiencing recurrent miscarriages, according to a study. The study, led by the University of...

Is There A Change In Microbial Life, Like Viruses?

With alarms sounded about the declining diversity of plants and animals, a related concern with equally profound implications is posed: Is the variety of...

‘Lost Golden City’ Of Luxor

By- Khushi Bisht Archeologists recently unearthed a 3000-year-old Egyptian wonder known as the 'Lost Golden City of Luxor,' near the 'Valley of Kings', a burial...

COVID Vaccine Might Be Less Effective For People With Blood Cancer: Study

The two-dose mRNA Covid-19 vaccine may be aless effective' in people undergoing treatment for certain types of blood cancers, researchers have claimed in two new...

Oral Antiviral Drug Shows Potential Prevention Against COVID-19

An experimental oral antiviral drug has shown potential in prevention and treatment of SARS-CoV-2, the virus causing Covid-19 infections, say researchers. The antiviral -- MK-4482...

Recent Comments